Search

Your search keyword '"van Haaps, Thijs F."' showing total 8 results
Start Over Author "van Haaps, Thijs F." Publication Type Academic Journals
8 results on '"van Haaps, Thijs F."'

2. Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer

Author

Guman, Noori A.M., van Geffen, Roos J., Mulder, Frits I., van Haaps, Thijs F., Hovsepjan, Vahram, Labots, Mariette, Cirkel, Geert A., de Vos, Filip Y.F.L., Ten Tije, Albert J., Beerepoot, Laurens V., Tjan‐Heijnen, Vivianne C.G., van Laarhoven, Hanneke W.M., Hamberg, Paul, Vulink, Annelie J.E., Los, Maartje, Zwinderman, Aeilko H., Ferwerda, Bart, Lolkema, Martijn P.J.K., Steeghs, Neeltje, Büller, Harry R., Kamphuisen, Pieter W., and van Es, Nick

Published
2021
Full Text
View/download PDF

6. Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study.

Author

van Haaps, Thijs F., Collard, Didier, van Osch, Frits H.M., Middeldorp, Saskia, Coppens, Michiel, de Kruif, Martijn D., Vlot, Eline A., Douma, Renée A., ten Cate, Hugo, Juffermans, Nicole P., Gritters, Niels, Vlaar, Alexander P., Reidinga, Auke C., Heuvelmans, Marjolein A., Oudkerk, Matthijs, Büller, Harry R., van den Bergh, Joop P.W., Maas, Arno, Ten Wolde, Marije, and Simsek, Suat

Subjects
*COVID-19, *HOSPITAL patients, *COHORT analysis, *ANTICOAGULANTS, *TREATMENT effectiveness
Abstract

• Hypercoagulability is a hallmark of COVID-19 patients. • It is unknown if pre-admission anticoagulant improves patient outcomes. • We studied 380 anticoagulant users and 380 matched controls with COVID-19. • Pre-admission anticoagulation was not associated with mortality and ICU admission. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

7. Interrater agreement of two scales on the severity of anticoagulant-related major bleeding in patients with venous thromboembolism.

Author

Guman, Noori A.M., van Haaps, Thijs F., van Es, Nick, Leeflang, Mariska M.G., Gerdes, Victor E.A., Middeldorp, Saskia, Büller, Harry R., and Kraaijpoel, Noémie

Subjects
*THROMBOEMBOLISM, *ANTICOAGULANTS, *HEMORRHAGE, *SEVERITY of illness index
Abstract

• Two classifications to assess major bleeding severity have been used in clinical trials. • Data on their interrater agreement and validity are lacking. • In this post-hoc analysis, the interrater agreement of the major bleeding severity scales was moderate to substantial. • Data incompleteness and subjective terminology may have led to discordant results. • Future studies should aim to improve methods to assess major bleeding severity. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results